Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
0.0242 EUR
241.22 M EUR
3.89 B EUR
9.24 B
About Sino Biopharmaceutical Limited
Sector
Industry
CEO
S Y Tse
Website
Headquarters
Hong Kong
Founded
2000
ISIN
KYG8167W1380
FIGI
BBG000CBMKG5
Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Investment, Modernised Chinese Medicines and Chemical Medicines; and Others. The Investment segment offers long-term investments. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long-term investments. The Other segment includes a research and development sector, which provides services to third parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse Cheung Ling Cheng and on February 2, 2000, and is headquartered in Hong Kong.
Related stocks
#1177 Good Support at $6.18 LevelHi Everybody
#1177 shows good support at $6.18 Level since July, it aims for the BLUE LINES, and stop if close below the RED Line.
LONG 1177Expecting bounce from extremely oversold weekly and daily levels. If stop breached, be prepared to catch new daily reversal on lower levels with a tight stop.
Double three of lesser degree formation possibleThe wave theory suggests HKEX:1177 that the prolong flat correction will be prolonged at least for the midterm period
Sino Biopharma- Double three in action. HKEX:1177
Current wave analysis suggests that the stock has already completed a regular flat and zig-zag action.
Price action suggest that the stock is heading for further downside correction as rising wedge formation gave some hint that the stock is losing its steam on bullish momentum.
Thursda
1177, Sino Biopharm - Trailing Stop and Ascending TriangleHKEX:1177
After our long entry on the head and shoulders of reversing, we are managing the position by gradually moving the stop profits below the last lows.
Currently an upward triangle is forming within our trailing stop, which if it broke the resistance level would probably further give a bullis
1177, Sino Biopharm - Trailing Stop after Breakingout on H&SHKEX:1177
Here too we continue to move the stop loss in trailing stop mode, until we reach our primary objective, that is Break Even Point, equal to the entry point plus commissions.
Remember that Risk Management and Position Sizing are the fundamental points to have a positive trading operation.
S
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange Sino Biopharmaceutical Limited stocks are traded under the ticker SMZ1.
We've gathered analysts' opinions on Sino Biopharmaceutical Limited future price: according to them, SMZ1 price has a max estimate of 1.34 EUR and a min estimate of 0.66 EUR. Watch SMZ1 chart and read a more detailed Sino Biopharmaceutical Limited stock forecast: see what analysts think of Sino Biopharmaceutical Limited and suggest that you do with its stocks.
SMZ1 reached its all-time high on Jul 23, 2020 with the price of 1.2900 EUR, and its all-time low was 0.0014 EUR and was reached on Feb 26, 2009. View more price dynamics on SMZ1 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
Yes, you can track Sino Biopharmaceutical Limited financials in yearly and quarterly reports right on TradingView.
Sino Biopharmaceutical Limited is going to release the next earnings report on Mar 26, 2026. Keep track of upcoming events with our Earnings Calendar.
SMZ1 earnings for the last half-year are 0.02 EUR per share, whereas the estimation was 0.01 EUR, resulting in a 56.67% surprise. The estimated earnings for the next half-year are 0.01 EUR per share. See more details about Sino Biopharmaceutical Limited earnings.
Sino Biopharmaceutical Limited revenue for the last half-year amounts to 2.08 B EUR, despite the estimated figure of 2.07 B EUR. In the next half-year revenue is expected to reach 1.93 B EUR.
SMZ1 net income for the last half-year is 393.50 M EUR, while the previous report showed 46.77 M EUR of net income which accounts for 741.31% change. Track more Sino Biopharmaceutical Limited financial stats to get the full picture.
Sino Biopharmaceutical Limited dividend yield was 2.19% in 2024, and payout ratio reached 65.98%. The year before the numbers were 1.44% and 35.95% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 30, 2025, the company has 24.38 K employees. See our rating of the largest employees — is Sino Biopharmaceutical Limited on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Sino Biopharmaceutical Limited EBITDA is 900.59 M EUR, and current EBITDA margin is 25.99%. See more stats in Sino Biopharmaceutical Limited financial statements.
Like other stocks, SMZ1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Sino Biopharmaceutical Limited stock right from TradingView charts — choose your broker and connect to your account.